Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 193.00
-1.00 (-0.52%)
Aug 28, 2026, 1:30 PM CST
Lotus Pharmaceutical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lotus Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $319.50. The average 1-year stock price forecast is 65.54% higher than the current stock price, while the lowest is $200.00 (+3.63%) and the highest is $500.00 (+159.07%).
Price Target: $319.50 (+65.54%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lotus Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
35.10B
from 20.51B
Increased by 71.16%
Revenue Next Year
41.54B
from 35.10B
Increased by 18.34%
EPS This Year
15.95
from 18.14
Decreased by -12.08%
EPS Next Year
25.20
from 15.95
Increased by 58.01%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.